Skip to content
Back to search results

Frontal Assessment Battery

Introduced by
Bruno Dubois
Year
2000
Type
Clinician-administered neuropsychological battery for frontal lobe function
Family
executive function and frontal lobe assessment
Font size

What does it do?

The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside.

Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function.

The intuition behind the method

The FAB samples the core executive functions mediated by the prefrontal cortex: the ability to form and shift between conceptual categories (conceptualization, mental flexibility), to plan and execute complex motor sequences (motor control), and to inhibit prepotent responses (inhibitory control). By combining these distinct components into a brief battery, the FAB efficiently screens for the 'executive syndrome' characteristic of frontal pathology. The total score of 0–18 provides a quick summary; individual subtest patterns reveal the specific nature of frontal dysfunction.

History

The FAB was developed by Bruno Dubois and colleagues at the Hôpital de la Salpêtrière in Paris and published in Neurology in 2000. It emerged from the need for a brief, bedside tool to screen for frontal lobe dysfunction in diverse clinical populations. The original validation study included patients with Alzheimer's disease, frontotemporal dementia, Parkinson's disease, and healthy controls. The FAB has since been extensively validated internationally and is now recommended in diagnostic criteria for frontotemporal dementia. Numerous translations exist, and normative data span multiple countries.

When to use it

The FAB is indicated for bedside screening of executive function and frontal pathology in patients with suspected neurodegenerative disease (particularly frontotemporal dementia or Parkinson's disease), stroke affecting prefrontal regions, traumatic brain injury, or behavioral or personality changes suggesting frontal lobe dysfunction. The FAB is NOT diagnostic and should be integrated with imaging, clinical assessment, and other neuropsychological tests. The FAB is particularly useful in busy clinical settings due to its brevity and minimal equipment needs.

Limitations and considerations

  • Limited sensitivity to mild frontal impairment — may not detect subtle executive dysfunction; more sensitive to moderate-to-severe frontal pathology.
  • Dependent on language and verbal ability — several subtests require verbal responses; aphasia or language difficulty can confound interpretation.
  • Not specific to frontal pathology — impaired FAB can arise from subcortical damage (e.g., striatum in Parkinson's disease), diffuse pathology, or attention/motivation problems.
  • Age and education effects — moderate correlations with age and education; norms should be consulted.

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Bedside practicality — requires only 10 minutes and minimal materials; no complex equipment.
  • Multidimensional assessment — samples distinct frontal functions (planning, flexibility, inhibition, conceptualization), not just a single executive process.
  • High sensitivity to frontotemporal dementia — FAB performance distinguishes frontotemporal dementia from Alzheimer's disease better than global cognitive screening tools.
  • Internationally validated — translated into 20+ languages with published norms across diverse populations.

Applications

  • Frontotemporal dementia screening: A neurologist evaluates a 58-year-old patient with progressive apathy and behavioral changes. MMSE is 27 (relatively normal), but FAB total is 9 with marked impairment in conceptualization (0/3) and motor programming (1/3) but intact inhibitory control. The FAB pattern is consistent with frontotemporal pathology; neuroimaging confirms frontal atrophy.
  • Parkinson's disease cognitive decline assessment: A movement disorders specialist uses the FAB to track executive function in a 70-year-old patient with Parkinson's disease. Baseline FAB is 14; one year later, FAB has declined to 10, with particular slowing on mental flexibility and motor programming subtests, consistent with Parkinson's cognitive decline.
  • Stroke executive dysfunction assessment: After a right middle cerebral artery stroke affecting prefrontal regions, a rehabilitation team administers the FAB to assess executive deficits. FAB is 8, with particular impairment in motor programming and sensitivity to interference, guiding cognitive rehabilitation focus.
  • Traumatic brain injury monitoring: A neuropsychologist uses serial FAB testing to monitor executive recovery in a patient with moderate TBI. FAB improves from 7 at 4 weeks post-injury to 12 at 12 weeks, documenting recovery in executive function and informing rehabilitation planning.

How it works

How it works

1

The FAB consists of 6 subtests, each requiring 1–2 minutes, for a total administration time of approximately 10 minutes. Subtests assess: (1) Conceptualization (similarities between objects, 0–3 points); (2) Mental Flexibility (categorical switching, 0–3 points); (3) Motor Programming (fist-palm-edge sequence, 0–3 points); (4) Sensitivity to Interference (Luria's conflicting instructions, 0–3 points); (5) Inhibitory Control (go/no-go task, 0–3 points); and (6) Environmental Autonomy (ability to resist grabbing objects placed in front of the patient, 0–3 points). All items are administered and scored by a clinician.

2

Each FAB subtest is scored on a 0–3 scale based on performance criteria. The total FAB score is obtained by summing subtest scores, yielding a range of 0 to 18. Higher scores indicate better frontal function. Interpretation typically uses a cutoff of <12 as indicative of frontal dysfunction, though cutoffs vary by population and clinical context.

3

A total FAB score of 16–18 indicates normal frontal function. Scores of 12–15 suggest mild frontal impairment. Scores of 8–11 indicate moderate frontal dysfunction. Scores <8 suggest severe frontal impairment. However, interpretation should focus on the pattern of subtest scores; differential impairment across subtests can indicate the specific type of frontal pathology (e.g., executive control vs. motor planning vs. conceptual reasoning).

Common pitfalls

  • Using FAB total score without examining individual subtests — the FAB pattern (e.g., marked motor planning impairment with intact conceptualization) can differentiate types of frontal pathology; total score alone misses this information.
  • Over-interpreting low FAB in severe dementia or delirium — the FAB may be low in any condition causing global cognitive impairment, not specifically frontal pathology.
  • Administering FAB in patients with severe aphasia or apraxia — language and motor requirements confound interpretation; consider alternative assessments.
  • Comparing FAB scores across serial visits without considering motivation and fatigue — FAB performance is vulnerable to low effort, fatigue, or depression; always assess cooperation.

Frequently asked questions

What should I do if a patient cannot perform the motor subtests (motor programming, inhibitory control) due to paresis?

Motor limitations confound interpretation of motor subtests. Document the motor deficit and interpret only the non-motor FAB items (conceptualization, flexibility, environmental autonomy). Consider alternative executive measures less dependent on motor performance (e.g., Wisconsin Card Sorting Test, Category fluency) if full assessment is needed.

Is the FAB useful for detecting cognitive decline in Alzheimer's disease?

The FAB is less sensitive to Alzheimer's pathology than to frontal pathology. Alzheimer's disease typically spares frontal function relatively early (memory and temporal dysfunction predominate), so FAB may be relatively normal despite significant overall cognitive impairment. The FAB is better suited to frontotemporal dementia screening. Use the MMSE or ADAS-Cog for Alzheimer's assessment.

What does an uneven FAB pattern indicate?

An uneven pattern (e.g., normal conceptualization but very low motor programming) suggests localized frontal pathology affecting specific motor-planning regions. In contrast, a uniformly low FAB suggests more global executive dysfunction or diffuse brain pathology. Individual subtest patterns can provide localization clues.

Can the FAB be administered remotely by videoconference?

Remote administration is feasible but reduces reliability, particularly for motor and sensitive-to-interference items that require precise observation. If videoconference administration is necessary, ensure high video quality, clear audio, and document the limitation. In-person administration is preferred.

Related methods

Sources

  1. Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626.

    Open DOI reference
    Copied.
  2. Slachevsky, A., Litvan, I., Marsiske, M., & Dubois, B. (2004). The FAB: A Frontal Assessment Battery at bedside for dementia and neurological conditions. In Dementia (pp. 123-146). Springer Publishing.

    Open publication reference
    Copied.
  3. Cummings, J. L., & Mega, M. (1994). Neuropsychiatry and behavioral neuroscience. Oxford University Press.

    Open publication reference
    Copied.